TGFB1 and neoplasm: In TNBC, AA7.1-mediated tumor inhibition occurred through the impairment in the TGF-β pathway, reduction in inflammatory cytokines (IL-17F), and the modulation of the protein content of extracellular vesicles, including vimentin [28].